Study supports prostate cancer benefits of tocotrienols
The link between Vitamin E and cancer benefits has received extra backing from a new study, which found that a mix of different forms of the vitamin helped prevent prostate tumor growth in mice.
The researchers chose to use the adenocarcinoma mouse prostate (TRAMP) mouse model because of its close resemblance to the various stages of human prostate cancer.
The complex used in the current study was the Tocomin branded blend supplied by Carotech, which contains D-α-tocotrienol (12–14%), D-β-tocotrienol (1%), D-γ -tocotrienol (18–20%), D-δ-tocotrienol (4–6%), and D-α-tocopherol (12–14%).
The researchers report that after their study period, mice in the Tocomin-supplemented group had a significantly lower occurrence of prostate tumors compared to the control.
